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Journal of Clinical & Translational Endocrinology 1 (2014) e1EditorialTranslational Research in EndocrinologyThe term “translational research” ﬁrst appeared on Pubmed in
1993 in a review by authors from the NIH calling for investigation
of biomarkers for the early detection of cancer [1]. Since that pub-
lication, over 7,000 manuscripts on Pubmed use the search term
“translational research.” Traditionally, translational research has
been used to describe research discoveries initiated at the bench
and then applied to human diseases aimed at improving health.
With the launch of the NIH Clinical and Translational Science
awards in 2006, the NIH further deﬁned translational research un-
der two major categories: 1) Studies that are generated in the lab-
oratory leading to development of clinical trials in humans and 2)
Research aimed at improving the adoption of evidence based med-
icine in the population [2].
An example of translational research in endocrinology that was
spawned by discoveries at the bench was a study published in Sci-
ence in 2006 proposing vitamin D as a potential mediator of the
anti-microbial response [3]. Following a series of in vitro experi-
ments, Liu and colleagues established that blood from vitamin D
deﬁcient African–American subjects did not induce an anti-
microbial response in cultured macrophages in vitro. However, af-
ter replacement of vitamin D in the blood, the anti-microbial
response could be restored. This important discovery spawned
several early pilot clinical studies to further evaluate vitamin D
for prevention and treatment of infections. These early translational
studies have demonstrated mixed results presumably due to timing
and dose of the vitamin D administration and the type of infection
under study. However, all of these studies continue to add to the
body of knowledge of the potential role of vitamin D as a therapeu-
tic target to help address infections in humans.
Publication of translational research is often challenging since
many early discoveries involve smaller pilot studies in which end-
points to establish clinical beneﬁt have not been adopted or
deﬁned. For example, in the above paper discussed, how does one
deﬁne optimal “anti-microbial response?” Additionally, larger
epidemiologic cross-sectional studies may examine biomarkers
established at the bench but that have not been validated in longi-
tudinal human trials. Moreover, research tools aimed at measuring
the successful adoption of evidence based medicine have yet to be
standardized.2214-6237 2014 Elsevier Inc.
http://dx.doi.org/10.1016/j.jcte.2013.11.001
Open access under CC BY-NC-ND license. Given these barriers to publication, Elsevier has created a new
journal entitled “Journal of Clinical and Translational Endocri-
nology” or JCTE. The purpose of JCTE is to create a home for manu-
scripts focused on translational and clinical endocrinology research.
The team of associate editors and editorial board are members of
the endocrinology research community who are heavily engaged
in clinical and translational research studies. We hope that re-
searchers consider this new journal for publication of their transla-
tional and clinical studies. For our readers, we hope that these
studies stimulate new ideas and provide new evidence to support
preclinical studies for improved human health. We welcome sub-
missions to our new journal at http://www.jctejournal.com/.Sincerely,
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